[시장보고서]심부전 POC 및 LOC 기기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 검사 유형별, 기술별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

심부전 POC 및 LOC 기기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 검사 유형별, 기술별, 최종 용도별, 지역별, 경쟁별(2020-2030년)

Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End Use, By Region & Competition, 2020-2030F

상품코드 : 1691815

리서치사 : TechSci Research

발행일 : 2025년 03월

페이지 정보 : 영문 186 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,151,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,519,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 10,936,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

심부전 POC 및 LOC 기기 세계 시장 규모는 2024년 1억 1,024만 달러로 2030년까지 8.25%의 CAGR로 예측 기간 동안 괄목할 만한 성장을 보일 것으로 예상됩니다.

심부전 POC 및 LOC 기기 세계 시장은 심부전 환자를 위해 특별히 설계된 혁신적인 진단 및 모니터링 기기의 시장 개발 및 출시에 초점을 맞춘 헬스케어 산업에서 빠르게 발전하고 있는 분야입니다. 이러한 기기는 심부전 감지, 관리 및 치료를 위해 보다 효율적이고 비용 효율적이며 환자 친화적인 솔루션을 제공하는 것을 목표로 합니다. 또한, 특정 개발은 세계 심부전 LOC 및 POC 기기 시장의 성장으로 이어질 것입니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	1억 1,024만 달러
시장 규모 : 2030년	1억 7,597만 달러
CAGR : 2025-2030년	8.25%
급성장 부문	유전체 검사
최대 시장	북미

랩온칩(LOC) 기술은 신속하고 높은 처리량의 분석을 가능하게 하여 질병 진단에 있어 사용 편의성과 신뢰성을 향상시키고 있습니다. 특히 심부전 등 심혈관계 질환(CVD)에 대한 LOC 기반 분석에 대한 R&D 투자 확대가 시장 성장의 원동력이 되고 있으며, CVD는 전 세계 사망원인 1위로, 조기 발견과 효과적인 관리의 필요성이 높아지면서 진단에 대한 LOC 기술의 수요가 증가하고 있습니다. 진단에 대한 LOC 기술의 수요를 높이고 있습니다. 의료의 분산화와 개인화된 의료로의 전환은 보다 빠르고 쉽게 이용할 수 있는 진단 솔루션을 제공하는 현장진단(POC) 및 LOC 기기의 채택을 가속화하고 있습니다. 정부 기관은 자금 지원과 규제 승인을 통해 LOC 개발을 적극적으로 지원하고 있으며, 이를 통해 기술 혁신을 촉진하고 있습니다.

시장 촉진요인

심부전 유병률 증가

주요 시장 과제

정확성과 신뢰성

주요 시장 동향

인공지능(AI) 통합

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 검사 유형별(단백질체 검사, 대사체 검사, 유전체 검사)
- 기술별(미세유체, 어레이 기반 시스템, 기타)
- 최종 용도별(병원, 외래 수술 센터, 재활 센터, 조사기관, 기타)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 심부전 POC 및 LOC 기기 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 심부전 POC 및 LOC 기기 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 영국
- 이탈리아
- 프랑스
- 스페인

제8장 아시아태평양의 심부전 POC 및 LOC 기기 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 남미의 심부전 POC 및 LOC 기기 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 심부전 POC 및 LOC 기기 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

최근 동향
제품 출시
인수합병

제13장 세계의 심부전 POC 및 LOC 기기 시장 : SWOT 분석

제14장 경쟁 구도

Abbott Laboratories Inc
Siemens Healthineers AG
Danaher Corp
Instrumentation Laboratory Co
F Hoffmann-La Roche AG
bioMerieux S.A.
Abaxis Inc
Quidel Corp
Jant Pharmacal Corp
Trinity Biotech plc

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

Global Heart Failure POC And LOC Devices Market was valued at USD 110.24 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.25% through 2030. The Global Heart Failure POC and LOC Devices Market refers to a rapidly evolving sector within the healthcare industry that focuses on the development and deployment of innovative diagnostic and monitoring devices specifically designed for heart failure patients. These devices aim to provide more efficient, cost-effective, and patient-friendly solutions for the detection, management, and treatment of heart failure. Also, certain development also leads to the growth of global heart failure LOC and POC devices market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 110.24 Million
Market Size 2030	USD 175.97 Million
CAGR 2025-2030	8.25%
Fastest Growing Segment	Genomic testing
Largest Market	North America

Lab-on-a-Chip (LOC) technology enables rapid, high-throughput analyses, improving ease of use and reliability in disease diagnosis. Growing R&D investments in LOC-based assays, particularly for cardiovascular diseases (CVD) such as heart failure, are driving market growth. With CVD being a leading cause of mortality worldwide, the increasing need for early detection and effective management is boosting demand for LOC technology in diagnostics. The shift towards decentralized healthcare and personalized medicine is accelerating the adoption of point-of-care (POC) and LOC devices, offering faster, more accessible diagnostic solutions. Government bodies are actively supporting LOC development through funding initiatives and regulatory approvals, encouraging further innovation.

Key Market Drivers

Rising Prevalence of Heart Failure

Heart failure is a pervasive and chronic cardiovascular condition, affecting millions of people worldwide. With an aging population, sedentary lifestyles, and an increasing prevalence of risk factors such as obesity and diabetes, the incidence of heart failure is on the rise. However, this health crisis has given rise to an opportunity for innovation in healthcare. The Global Heart Failure Point of Care (POC) and Lab on a Chip (LOC) Devices Market is experiencing remarkable growth due to the escalating prevalence of heart failure.

Diabetes is a global health crisis, placing a substantial burden on developing countries like India, which is often referred to as the diabetes capital of the world. According to the ICMR-INDIAB study, over 101 million people in India are living with diabetes. The disease is linked to high morbidity and mortality, with nearly 46% of diabetic patients developing cardiovascular disease (CVD) during their lifetime. CVD is a leading cause of death among Type 2 diabetes (T2D) patients, accounting for nearly 50% of diabetes-related fatalities. Approximately 30% of diabetic patients develop heart failure, and those with both T2D and heart failure face an eightfold higher risk of death compared to individuals without heart failure. These alarming statistics highlight the urgent need for early diagnosis, intervention, and innovative treatment strategies to reduce the impact of diabetes-related cardiovascular complications.

Key Market Challenges

Accuracy and Reliability

POC and LOC devices need to be highly accurate and reliable, as errors can lead to misdiagnoses or improper management of heart failure. Ensuring consistent accuracy remains a significant challenge, especially for smaller and portable devices.

Key Market Trends

Integration of Artificial Intelligence (AI)

Artificial intelligence is increasingly being incorporated into POC and LOC devices. AI can enhance diagnostic accuracy, personalize treatment plans, and provide predictive analytics to identify potential heart failure exacerbations before they occur.

Key Market Players

Abbott Laboratories Inc
Siemens Healthineers AG
Danaher Corp
Instrumentation Laboratory Co
F Hoffmann-La Roche AG
bioMerieux S.A.
Abaxis Inc
Quidel Corp
Jant Pharmacal Corp
Trinity Biotech plc

Report Scope:

In this report, the Global Heart Failure POC And LOC Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Failure POC And LOC Devices Market, By Test Type:

Proteomic testing
Metabolomic testing
Genomic testing

Heart Failure POC And LOC Devices Market, By Technology:

Microfluidics
Array-based systems
Others

Heart Failure POC And LOC Devices Market, By End Use:

Clinics
Hospitals
Home
Assisted living healthcare facilities
Laboratory
Others

Heart Failure POC And LOC Devices Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Failure POC And LOC Devices Market.

Available Customizations:

Global Heart Failure POC And LOC Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Source
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Failure POC And LOC Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Test Type (Proteomic testing, Metabolomic testing, Genomic testing)
- 5.2.2. By Technology (Microfluidics, Array-based systems, Others)
- 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Rehabilitation Centers, Research Institutes, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Heart Failure POC And LOC Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Technology
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Heart Failure POC And LOC Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By End User
- 6.3.2. Canada Heart Failure POC And LOC Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By End User
- 6.3.3. Mexico Heart Failure POC And LOC Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By End User

7. Europe Heart Failure POC And LOC Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Technology
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Heart Failure POC And LOC Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By End User
- 7.3.2. United Kingdom Heart Failure POC And LOC Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By End User
- 7.3.3. Italy Heart Failure POC And LOC Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By End User
- 7.3.4. France Heart Failure POC And LOC Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Heart Failure POC And LOC Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By End User

8. Asia-Pacific Heart Failure POC And LOC Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Technology
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Heart Failure POC And LOC Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By End User
- 8.3.2. India Heart Failure POC And LOC Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By End User
- 8.3.3. Japan Heart Failure POC And LOC Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By End User
- 8.3.4. South Korea Heart Failure POC And LOC Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Heart Failure POC And LOC Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By End User

9. South America Heart Failure POC And LOC Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Technology
- 9.2.3. By End User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Heart Failure POC And LOC Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By End User
- 9.3.2. Argentina Heart Failure POC And LOC Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By End User
- 9.3.3. Colombia Heart Failure POC And LOC Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By End User

10. Middle East and Africa Heart Failure POC And LOC Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Technology
- 10.2.3. By End User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Heart Failure POC And LOC Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Heart Failure POC And LOC Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By End User
- 10.3.3. UAE Heart Failure POC And LOC Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By End User
- 10.3.4. Kuwait Heart Failure POC And LOC Devices Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Type
    - 10.3.4.2.2. By Technology
    - 10.3.4.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Heart Failure POC And LOC Devices Market: SWOT Analysis

14. Competitive Landscape

14.1. Abbott Laboratories Inc
- 14.1.1. Business Overview
- 14.1.2. Technology Offerings
- 14.1.3. Recent Developments
- 14.1.4. Key Personnel
- 14.1.5. SWOT Analysis
14.2. Siemens Healthineers AG
14.3. Danaher Corp
14.4. Instrumentation Laboratory Co
14.5. F Hoffmann-La Roche AG
14.6. bioMerieux S.A.
14.7. Abaxis Inc
14.8. Quidel Corp
14.9. Jant Pharmacal Corp
14.10.Trinity Biotech plc